Should I buy Albemarle Corporation (ALB) stock or is it too late?

Albemarle Corporation · Materials · price $98

See the full Albemarle Corporation (ALB) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (185 calls tested). It aims for $150 (+54 %), call made on October 6, 2026, maturing on October 6, 2027 (8 d ago).

The 9 reliable analysts $157+61 %

The 9 other firms $192+97 %

How to read it: the 9 reliable firms are not filtered by optimism — 9 aim above the price, 0 below, hence their $157 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Albemarle Corporation

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
UBS	69 %	+68.1 %	13	$150 +54%
Jefferies	58 %	+29.5 %	12	$230 +136%
BMO Capital	44 %	+26.6 %	9	$200 +105%
Deutsche Bank	40 %	+0.3 %	20	$250 +156%
Keybanc	29 %	-3.8 %	34	$87 -11%
Oppenheimer	27 %	-10.5 %	15	$207 +112%
B of A Securities	33 %	-12.0 %	9	$155 +59%
Citigroup	36 %	-25.1 %	22	$175 +79%

In short — Should you invest in Albemarle Corporation? Is it too late, still worth it? Analysts are fairly positive (56% buy, median target $178, i.e. +82%), and the most reliable on ALB targets even higher. But the valuation is stretched (P/E ~362). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $178, i.e. +82% from the current price ($98).
The most reliable firm on ALB, UBS (69% hit rate, 13 scored calls), targets $150 (call made on October 5, 2026, maturing on October 5, 2027) (+54%) in its most recent call, and $230 (call made on April 9, 2026, maturing on April 9, 2027) (+136%) in the one coming due soonest.
6 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 18 ratings, 8 are neutral.
High valuation (P/E ~362): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on ALB

Median target $178 (+82%) · 18 ratings · Buy consensus

Strong Buy00%

Buy1056%

Hold844%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Albemarle Corporation now?

We won't decide for you. The facts: 56% of analysts rate it a buy, median target $178 (+82%), and UBS (most reliable on ALB, 69%) targets $150. Weigh that against valuation (P/E ~362). This is not personalized advice.

Is it too late to invest in Albemarle Corporation?

Not according to analysts: the median target ($178) is still +82% above the current price ($98) (most reliable on ALB: UBS, 69%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Albemarle Corporation still worth investing in?

It depends on the gap between the price ($98) and its estimated value: analysts target $178 on median (+82%), with 56% buys (most reliable on ALB: UBS, 69%). Cross-check with their real reliability on ALB and the cautions above. Information, not advice.

What's the main risk in buying ALB?

The consensus is not unanimous: of 18 ratings, 8 are neutral.

→ Go deeper: the full Albemarle Corporation profile (consensus, analyst reliability, price target, performance).